home / stock / syrs / syrs quote
Last: | $5 |
---|---|
Change Percent: | -1.01% |
Open: | $4.98 |
Close: | $5 |
High: | $5.0443 |
Low: | $4.8501 |
Volume: | 49,811 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5 | $4.98 | $5 | $5.0443 | $4.8501 | 49,811 | 07-02-2024 |
$4.93 | $5.06 | $4.93 | $5.165 | $4.9 | 55,276 | 07-01-2024 |
$5.16 | $5.72 | $5.16 | $5.72 | $4.89 | 182,485 | 06-28-2024 |
$5.73 | $5.7 | $5.73 | $5.755 | $5.62 | 37,267 | 06-27-2024 |
$5.7 | $5.75 | $5.7 | $5.82 | $5.63 | 79,368 | 06-26-2024 |
$5.8 | $5.81 | $5.8 | $5.89 | $5.6442 | 153,213 | 06-25-2024 |
$5.81 | $5.46 | $5.81 | $5.85 | $5.46 | 71,794 | 06-24-2024 |
$5.58 | $5.33 | $5.58 | $5.58 | $5.151 | 95,381 | 06-21-2024 |
$5.31 | $5.33 | $5.31 | $5.37 | $5.16 | 72,975 | 06-20-2024 |
$5.34 | $5.61 | $5.34 | $5.61 | $5.24 | 126,056 | 06-19-2024 |
$5.34 | $5.61 | $5.34 | $5.61 | $5.24 | 126,056 | 06-18-2024 |
$5.71 | $6.01 | $5.71 | $6.0599 | $5.71 | 136,141 | 06-17-2024 |
$6 | $5.82 | $6 | $6.1199 | $5.76 | 141,869 | 06-14-2024 |
$5.8 | $5.33 | $5.8 | $5.82 | $5.3201 | 88,070 | 06-13-2024 |
$5.4 | $5.25 | $5.4 | $5.47 | $5.25 | 95,427 | 06-12-2024 |
$5.25 | $5.11 | $5.25 | $5.305 | $5.05 | 83,905 | 06-11-2024 |
$5.12 | $5.11 | $5.12 | $5.18 | $4.96 | 55,071 | 06-10-2024 |
$5.15 | $5.25 | $5.15 | $5.29 | $4.96 | 74,094 | 06-07-2024 |
$5.3 | $5.3 | $5.3 | $5.34 | $5.19 | 54,733 | 06-06-2024 |
$5.3 | $5.25 | $5.3 | $5.39 | $5.1971 | 67,572 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Syros Pharmaceuticals Inc. Company Name:
SYRS Stock Symbol:
NASDAQ Market:
Syros Pharmaceuticals Inc. Website:
2024-06-18 10:10:00 ET June 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform covering biotech and medical technology stocks releases the second of a two-part series looking at developments for the treatment of blood cancers, including AML, featuring A...
-- Three medical experts will join members of Syros’ leadership team to provide an overview of HR-MDS patient management, perspectives on the current and future treatment landscape, and the opportunity for tamibarotene on Tuesday, June 25 at 11:00 a.m. ET -- -- Syros expects to rep...
2024-05-27 04:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...